胰头癌胰腺切除术中静脉血管切除:技术问题还是预后标志?
静脉血管切除与更高的并发症发生率、R1切除率和神经侵犯相关,且是较差无病生存的独立预测因素,但两组90天术后死亡率无差异。
要点
- 静脉血管切除可安全完成,不增加90天术后死亡率。
- 静脉血管切除与R1切除、神经侵犯等不良预后因素相关。
- 静脉血管切除是肿瘤复发的显著独立预测因素。
核心结论
- 胰腺切除术中静脉血管切除可安全实施,但与不良预后因素相关并预示更差的临床结局,是癌症复发的显著预测因素。
主要发现
- 静脉血管切除组并发症发生率更高(64% vs 54%;P = .026),但90天术后死亡率无差异(3.1% vs 2.8%;P = .5)。
- 静脉血管切除与R1切除显著相关(52% vs 37%;P = .002),与神经侵犯显著相关(87% vs 77%;P = .017)。
- 静脉血管切除组与未切除组的5年无病生存率分别为7%和20%(P = .018)。
- 无病生存较差的独立预测因素包括静脉血管切除、淋巴结阳性状态和神经侵犯。
- 疾病特异生存较差的独立预测因素为神经侵犯和淋巴结阳性状态,辅助治疗为保护因素;两组5年疾病特异生存率分别为19%和35%(P = .42)。
临床怎么用
- 静脉血管切除本身不增加90天术后死亡风险,可安全用于需血管切除的胰头癌患者。
- 静脉血管切除提示不良预后因素(R1切除、神经侵犯)和复发风险增高,术后应加强随访和辅助治疗。
局限性
- 本研究为回顾性分析,尽管采用倾向性评分匹配,仍可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is an increased interest in venous vascular resection associated with pancreatic resection for pancreatic ductal adenocarcinoma as an upfront procedure or after neoadjuvant treatment. The aim of this study was to evaluate the impact of venous vascular resection for pancreatic ductal adenocarcinoma on postoperative and long-term outcomes. METHODS: The study is a retrospective analysis of patients who underwent pancreatectomy for pancreatic head pancreatic ductal adenocarcinoma with and without venous vascular resection between January 2010 and April 2018. The impact of venous vascular resection on postoperative and pathologic data was analyzed. Univariate and multivariate analyses of predictors of disease-free and disease-specific survival were analyzed for the entire cohort. A propensity-score matched cohort analysis was subsequently performed to remove selection bias and improve homogeneity. RESULTS: Four hundred and eighty-one patients were included, and 126 (26%) underwent a venous vascular resection. Patients undergoing venous vascular resection had higher morbidity (64% vs 54%; P = .026) with no differences in 90-day postoperative mortality (3.1 vs 2.8%; P = .5). Venous vascular resections were also significantly associated with R1 resections (52% vs 37%; P = .002) and perineural invasion (87% vs 77%; P = .017). Five-year disease-free survival in patients with and without venous vascular resection were 7% and 20% (P = .018), respectively. Independent predictors of worse disease-free survival included venous vascular resection, positive lymph node status, and perineural invasion. Independent predictors of worse disease-specific survival were perineural invasion and positive nodal status, while adjuvant treatment was a protective factor. Five-year disease-specific survival in patients with and without venous vascular resection were 19% and 35% (P = .42). CONCLUSION: Pancreatectomy with venous vascular resection can be accomplished safely. Venous vascular resections are associated with poor prognostic factors and with a worse clinical outcome, being a significant predictor of cancer recurrence.
引用
- Belfiori G, Fiorentini G, Tamburrino D, et al. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign? Surgery. 2020. PMID: 32912782. doi:10.1016/j.surg.2020.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。